Skip to main content

Calidi Biotherapeutics, Inc.

CLDI
Exchange
NYSE
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001855485

No open-market purchases or sales by Calidi Biotherapeutics, Inc. insiders were filed in the last 90 days; 23 institutions reported holding it in 13F filings for Q2 2026, worth $89.3K in total; no superinvestor holds it.

Other share classesCLDWW

Q4 2024 vs. Q3 2024

How the institutions holding Calidi Biotherapeutics, Inc. changed between Q3 2024 and Q4 2024.

All holders in Q4 2024All holders in Q3 2024

13F holders of CLDI: Q3 2024 compared with Q4 2024
MeasureQ3 2024Q4 2024Change
Holders2033+13
Shares319.3K1.10M+783.0K (+245.2%)
Value$363.4K$1.27M+$903.3K (+248.6%)

New holders (18)

Institutions that held Calidi Biotherapeutics, Inc. at the end of Q4 2024 but not at the end of Q3 2024.

Institutions new to CLDI in Q4 2024
InstitutionSharesValue% of portfolio
Millennium Management LLC136,137$156.6K0.00%
HighTower Advisors, LLC102,276$117.6K0.00%
Drive Wealth Management, LLC90,000$103.5K0.03%
Virtu Financial LLC73,448$84.0K0.00%
Vanguard Group Inc61,374$70.6K0.00%
RS Crum Inc.40,463$46.5K0.01%
Jane Street Group, LLC33,437$38.5K0.00%
State Street Corp22,790$26.2K0.00%
Northern Trust Corp19,933$22.9K0.00%
Goldman Sachs Group Inc17,509$20.1K0.00%
HRT Financial LP15,751$18.0K0.00%
Bank of Montreal12,500$14.4K0.00%
Avidian Wealth Solutions, LLC10,000$11.5K0.00%
Grassi Investment Management10,000$11.0K0.00%
Royal Bank of Canada5,000$6.00K0.00%
Barrett & Company, Inc.3,500$4.03K0.00%
IFP Advisors, Inc3,500$4.03K0.00%
Tradewinds Capital Management, LLC1,000$1.15K0.00%

Sold out (5)

Institutions that held Calidi Biotherapeutics, Inc. at the end of Q3 2024 and filed for Q4 2024 without it.

Institutions that sold out of CLDI in Q4 2024
InstitutionShares, Q3 2024Value, Q3 2024
Cable Car Capital LLC82,937$94.5K
683 Capital Management, LLC3,788$4.32K
Tower Research Capital LLC (TRC)3,671$4.18K
FMR LLC141$161
Householder Group Estate & Retirement Specialist, LLC500$0